KALV logo

KalVista Pharmaceuticals, Inc. (KALV)

Profile

Full Name

KalVista Pharmaceuticals, Inc.

Ticker

NASDAQ: KALV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 9, 2015

Indexes

Not included

Website

https://www.kalvista.com

Employees

270

Key Details

Price

$14.21(-4.02%)

Market cap

$715.58M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$3.69(-7.27% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.21
    KALV price is $14.21

    30-Day Relative Volume

    1.76
    KALV 30-day relative volume is 1.76

    Price Performance

    Price Today change

    -4.02%
    KALV price is down -4.02% today

    Price YTD change

    +67.83%
    KALV price is up +67.83% since January 1st

    Price 1-year change

    +35.9%
    KALV price is up +35.9% year-on-year

    Price 3-year change

    -8.59%
    KALV price is down -8.59% over the past 3 years

    Price Range

    Price All-time high

    $129.11
    KALV price is currently -88.99% below its historical high of $129.11

    Price 3-year low

    $4.12
    KALV price is currently +245.02% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $715.58M
    KALV market capitalization is $715.58 million

    Market cap 3-year change

    +87.05%
    KALV market capitalization is up +87.05% over the past 3 years

    Market cap All-time high

    $1.02B
    KALV market capitalization is currently -29.77% below its historical high of $1.02 billion

    Market cap sector rank

    67.98%
    KALV market capitalization is higher than 67.98% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +16.49%
    KALV shares outstanding is up +16.49% year-on-year

    Shares Outstanding 3-Year Change

    +104.62%
    KALV shares outstanding is up +104.62% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.73
    KALV beta is 0.73

    200-day SMA

    $11.66
    KALV price is currently +21.87% above its 200-day simple moving average

    50-day SMA

    $14.06
    KALV price is currently +1.07% above its 50-day simple moving average

    RSI

    56.79
    KALV 14-day relative strength index is 56.79

    Volume

    1.76
    KALV 30-day relative volume is 1.76

    ATR

    $0.94
    KALV average true range is $0.94

    10-day Historical Volatility

    58.72%
    KALV 10-day historical volatility is 58.72%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    KALV annual revenue is $0.00

    Revenue Analysts estimate

    $47.35M
    KALV annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    0%
    KALV annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.73%
    KALV annual revenue is higher than 28.73% of companies in Healthcare sector

    EPS

    EPS

    -$3.69
    KALV annual earnings per share is -$3.69

    EPS Analysts estimate

    -$3.16
    KALV annual earnings per share is currently +16.93% higher than the consensus analysts' forecast

    EPS 1-year change

    -7.27%
    KALV annual earnings per share is down -7.27% year-on-year

    EPS Sector rank

    24.64%
    KALV annual earnings per share is higher than 24.64% of companies in Healthcare sector

    Profit

    Gross profit

    -$941.00K
    KALV annual gross profit is -$941.00 thousand

    Gross margin

    -
    KALV annual gross profit margin value is unknown

    Operating profit

    -$182.98M
    KALV annual operating income is -$182.98 million

    Operating margin

    -
    KALV annual operating profit margin value is unknown

    Net income

    -$183.44M
    KALV annual net profit is -$183.44 million

    Net margin

    -
    KALV annual net profit margin value is unknown

    Expenses

    Total expenses

    $182.98M
    KALV annual total expenses is $182.98 million

    Operating expenses

    $182.98M
    KALV annual total operating expenses is $182.98 million

    Cost of goods sold

    $941.00K
    KALV annual cost of goods sold is $941.00 thousand

    Selling, general & administrative expenses

    $116.29M
    KALV annual SGA is $116.29 million

    Depreciation and amortization

    $941.00K
    KALV annual depreciation & amortization is $941.00 thousand

    Interest expense

    $0.00
    KALV annual interest expense is $0.00

    Income tax

    -$1.62M
    KALV annual income tax is -$1.62 million

    EBIT & EBITDA

    EBIT

    -$174.27M
    KALV annual earnings before interest & taxes is -$174.27 million

    EBITDA

    -$173.33M
    KALV annual EBITDA is -$173.33 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $250.77M
    KALV annual total assets is $250.77 million

    Non current assets

    $9.08M
    KALV annual long term assets is $9.08 million

    Current assets

    $241.69M
    KALV annual total current assets is $241.69 million

    Cash and cash equivalents

    $131.62M
    KALV annual cash & cash equivalents is $131.62 million

    Accounts receivable

    -
    KALV annual accounts receivable value is unknown

    Inventory

    $0.00
    KALV annual inventory is $0.00

    Liabilities

    Total liabilities

    $155.38M
    KALV annual total liabilities is $155.38 million

    Long term liabilities

    $110.21M
    KALV annual total long term liabilities is $110.21 million

    Current liabilities

    $45.17M
    KALV annual total current liabilities is $45.17 million

    Accounts payable

    $4.88M
    KALV annual accounts payable is $4.88 million

    Debt

    Total debt

    $112.19M
    KALV annual total debt is $112.19 million

    Total debt 1-year change

    +1433.26%
    KALV annual total debt is up +1433.26% year-on-year

    Long term debt

    $110.21M
    KALV annual long term debt is $110.21 million

    Short term debt

    $1.98M
    KALV annual short term debt is $1.98 million

    Equity & Capital

    Shareholders equity

    $95.39M
    KALV annual stockholders equity is $95.39 million

    Book value

    $95.39M
    KALV annual book value is $95.39 million

    Retained earnings

    -$653.17M
    KALV annual retained earnings is -$653.17 million

    Working capital

    $196.52M
    KALV annual working capital is $196.52 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$152.91M
    KALV annual cash flow from operations is -$152.91 million

    Cash from operations 1-year change

    -71.36%
    KALV annual cash flow from operations is down -71.36% year-on-year

    Cash from investing

    $91.02M
    KALV annual cash flow from investing activities is $91.02 million

    Cash from investing 1-year change

    +207.44%
    KALV annual cash flow from investing activities is up +207.44% year-on-year

    Cash from financing

    $159.73M
    KALV annual cash flow from financing activities is $159.73 million

    Cash from financing 1-year change

    +5.98%
    KALV annual cash flow from financing activities is up +5.98% year-on-year

    CAPEX

    CAPEX

    $929.00K
    KALV annual capital expenditures is $929.00 thousand

    CAPEX 1-year change

    +109.71%
    KALV annual capital expenditures is up +109.71% year-on-year

    Free Cash Flow

    Free cash flow

    -$153.84M
    KALV annual free cash flow is -$153.84 million

    Free cash flow 1-year change

    -71.55%
    KALV annual free cash flow is down -71.55% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    KALV annual gross profit margin value is unknown

    Operating margin

    -
    KALV annual operating profit margin value is unknown

    Net margin

    -
    KALV annual net profit margin value is unknown

    ROA & ROE

    ROA

    -75.46%
    KALV annual return on assets is -75.46%

    ROE

    -121.50%
    KALV annual return on equity is -121.50%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    KALV price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    KALV price to earnings ratio is unknown

    PB Ratio

    PB ratio

    7.50
    KALV price to book ratio is 7.50

    PB ratio Sector rank

    85.17%
    KALV price to book ratio is higher than 85.17% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    KALV price to sales ratio value is unknown

    PS ratio Sector rank

    -
    KALV price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $607.15M
    KALV enterprise value is $607.15 million

    Enterprise value Sector rank

    68.05%
    KALV enterprise value is higher than 68.05% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.25
    KALV EV/EBITDA is -3.25

    EV/EBITDA Sector rank

    28.92%
    KALV EV/EBITDA is higher than 28.92% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.35
    KALV annual current ratio is 5.35

    Quick ratio

    5.35
    KALV annual quick ratio is 5.35

    Leverage

    Debt to equity

    1.18
    KALV annual debt to equity ratio is 1.18

    Interest coverage ratio

    -
    KALV annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    KALV piotroski f-score value is unknown

    Altman Z-Score

    -2.24
    KALV altman z-score is -2.24

    Analyst ratings

    Recent major analysts updates

    Jul 11, 25 HC Wainwright & Co.
    Buy
    Jul 8, 25 JMP Securities
    Market Outperform
    Jul 8, 25 HC Wainwright & Co.
    Buy
    Jul 7, 25 Leerink Partners
    Outperform
    Apr 8, 25 Needham
    Buy
    Mar 26, 25 Needham
    Buy
    Mar 26, 25 Jones Trading
    Buy
    Mar 26, 25 Citizens Capital Markets
    Market Outperform
    Mar 14, 25 HC Wainwright & Co.
    Buy
    Mar 13, 25 Needham
    Buy

    Institutional Ownership

    Screeners with KALV included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for KalVista Pharmaceuticals, Inc.?
    • Does KalVista Pharmaceuticals, Inc. pay dividends?
    • What sector is KalVista Pharmaceuticals, Inc. in?
    • What industry is KalVista Pharmaceuticals, Inc. in?
    • What country is KalVista Pharmaceuticals, Inc. based in?
    • When did KalVista Pharmaceuticals, Inc. go public?
    • Is KalVista Pharmaceuticals, Inc. in the S&P 500?
    • Is KalVista Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is KalVista Pharmaceuticals, Inc. in the Dow Jones?
    • When was KalVista Pharmaceuticals, Inc.'s last earnings report?
    • When does KalVista Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for KalVista Pharmaceuticals, Inc.?

    The ticker symbol for KalVista Pharmaceuticals, Inc. is NASDAQ:KALV

    Does KalVista Pharmaceuticals, Inc. pay dividends?

    No, KalVista Pharmaceuticals, Inc. does not pay dividends

    What sector is KalVista Pharmaceuticals, Inc. in?

    KalVista Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is KalVista Pharmaceuticals, Inc. in?

    KalVista Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is KalVista Pharmaceuticals, Inc. based in?

    KalVista Pharmaceuticals, Inc. is headquartered in United States

    When did KalVista Pharmaceuticals, Inc. go public?

    KalVista Pharmaceuticals, Inc.'s initial public offering (IPO) was on April 9, 2015

    Is KalVista Pharmaceuticals, Inc. in the S&P 500?

    No, KalVista Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is KalVista Pharmaceuticals, Inc. in the NASDAQ 100?

    No, KalVista Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is KalVista Pharmaceuticals, Inc. in the Dow Jones?

    No, KalVista Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was KalVista Pharmaceuticals, Inc.'s last earnings report?

    KalVista Pharmaceuticals, Inc.'s most recent earnings report was on September 11, 2025

    When does KalVista Pharmaceuticals, Inc. report earnings?

    The date for KalVista Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page